| Sugar-sweetened orange beverages: A silent risk factor for colorectal cancer? |
41610179
|
Singh D, Liu J, Luo J, Huang L, Huang QS, Yang L, Zhou Z |
Nutr Health |
2026 |
PLCO |
| Methylation Biomarker of Chronic Heavy Alcohol Consumption (HAC), but Not Acute HAC, Predicts All-Cause Mortality in Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. |
41595490
|
Beach SRH, Mills JA, Long JD, Philibert RA |
Genes (Basel) |
2026 |
PLCO |
| Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. |
41582658
|
O'Connell CP, Berndt SI, Chudy-Onwugaje K, Kunzmann A, Huang WY, Barry KH, Loftfield E |
Cancer |
2026 |
PLCO |
| Predicting Long-Term Risk for Prostate Cancer Mortality Following a Prostate-Specific Antigen Screening Test: Prognostic Model Development and External Validation. |
41525694
|
Lewicki P, Jiang R, Radhakrishnan A, Bryant A, Schipper M, Morgan TM, Stensland K |
Ann Intern Med |
2026 |
PLCO |
| Correction to "Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial". |
41711095
|
|
Cancer |
2026 |
PLCO |
| Comment on "Association of aspirin and ibuprofen use with endometrial cancer risk in the PLCO dataset". |
41709736
|
Lai SW, Liao KF |
Int J Cancer |
2026 |
PLCO |
| Etiologic heterogeneity across oral cavity cancers. |
41701516
|
Yano Y, Tota JE, Graubard BI, Liao LM, Kahle L, Cheung LC, Abnet CC, Chaturvedi AK |
Cancer |
2026 |
PLCO |
| Pre-diagnostic immunological markers of bacterial translocation and liver cancer risk: A nested case-control analysis of 12 prospective cohorts. |
41129365
|
Watling CZ, Campbell PT, Graubard BI, Wang Y, Gewirtz AT, Zhang X, Barnett MJ, Buring JE, Chen Y, Eliassen AH, Gaziano JM, Hofmann JN, Huang WY, Kang JH, Koshiol J, Loftfield E, Lee IM, Moore SC, Mucci LA, Neuhouser ML, Newton CC, Purdue MP, Sesso H… |
Int J Cancer |
2026 |
PLCO |
| Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analyses. |
40910475
|
Moore A, Kane E, Teras LR, Machiela MJ, Arias J, Panagiotou OA, Monnereau A, Doo NW, Wang Z, Slager SL, Vermeulen RCH, Vajdic CM, Smedby KE, Spinelli JJ, Vijai J, Giles GG, Link BK, Arslan AA, Nieters A, Bracci PM, Camp NJ, Salles G, Cozen W, Hjalgr… |
Int J Cancer |
2026 |
PLCO |
| Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. |
41206949
|
Zhang T, Hua X, Mohindroo C, Wang X, Dutta D, Liu J, Katta S, Li SA, Wang J, Antwi SO, Arslan AA, Beane Freeman LE, Bracci PM, Canzian F, Du M, Gallinger S, Goodman PJ, Katzke V, Kooperberg C, Le Marchand L, Neale RE, Patel AV, Perdomo S, Shu XO, Vi… |
J Natl Cancer Inst |
2026 |
PLCO |
| Predictive prioritization of enhancers associated with pancreatic disease risk. |
41106391
|
Wang L, Baek S, Prasad G, Wildenthal J, Guo K, Sturgill D, Truongvo T, Char E, Pegoraro G, McKinnon K, Pancreatic Cancer Cohort Consortium, Pancreatic Cancer Case-Control Consortium, Hoskins JW, Amundadottir LT, Arda HE |
Cell Genom |
2026 |
PLCO |
| Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer. |
41223770
|
Billaud A, Figlioli G, Mooser C, Casamassima I, Azzoni V, Srivatsa J, Colombo M, Caleca L, Ahearn TU, Andrulis IL, Antoniou AC, Beckmann MW, Behrens S, Bermisheva M, Bogdanova NV, Bolla MK, Bonanni B, Brüning T, Camp NJ, Campbell A, Castelao JE, Ces… |
Breast |
2026 |
PLCO |
| Association Between the Dietary Index for Gut Microbiota (DI-GM) and Colorectal Cancer in the PLCO Cohort. |
41978138
|
Kase BE, Liese AD, Zhang J, Murphy EA, Steck SE |
Nutrients |
2026 |
PLCO |
| Correlates of Serum Concentrations of Biomarkers Relevant to Ovarian Cancer Screening. |
42018468
|
Akonde M, Graybill WS, Clay-Gilmour A, Zhang J, Alberg AJ |
J Appl Lab Med |
2026 |
PLCO |
| Multimodal Deep Learning for Pulmonary Nodule Detection on Chest Radiography in High-Risk Adults, With Secondary Validation for All-Cause and Cause-Specific Mortality Prediction: A Multicenter Cohort Study. |
41969630
|
Li J, Xing Y, Gao X, Liu Y, Zhang L, Huang Y, Zhang P, Ye Z, Wang M, Song F |
MedComm (2020) |
2026 |
PLCO |
| A synthetic oversampling-based customized ResNet51-Conv1D framework for early colorectal cancer prediction using structured clinical data from the PLCO screening trial. |
41965613
|
Prasath ST, Asha MM, Nagarajan B, Yesuraj R, Prathapchandran K, Sreeraman Y |
BMC Med Inform Decis Mak |
2026 |
PLCO |
| Metabolomic signature of ultra-processed foods and cardiovascular morbidity and mortality. |
42217336
|
Wang L, Yang J, Chen J, Rebholz CM, Shu XO, Shrubsole MJ, Gupta DK, Lipworth L, Ma S, Dai Q, Zheng W, Yu D |
Clin Nutr |
2026 |
PLCO |
| Racial and ethnic differences in prostate cancer screening outcomes in the United States: A secondary analysis of the prostate, lung, colorectal, and ovarian cancer trial. |
42173201
|
Joung HH, Martin DN, Jones RA |
Prev Med |
2026 |
PLCO |
| Association between planetary health diet index and lung cancer risk in 106,542 participants: a prospective cohort study. |
42137860
|
Zhu J, Gu H, Zeng Z, Xiao Y, Shi Y, Me Z, Peng L, Xiang L, Luo Y, Chen Y, Jiang X |
Front Nutr |
2026 |
PLCO |
| Cardiometabolic comorbidities and prostate cancer risk: evidence from the prostate, lung, colorectal, and ovarian cancer screening trial. |
42137169
|
Zhu Q, Zeng L, Chen M |
Front Oncol |
2026 |
PLCO |
